157 related articles for article (PubMed ID: 24416990)
21. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
22. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.
Hahn HS; Chun YK; Kwon YI; Kim TJ; Lee KH; Shim JU; Mok JE; Lim KT
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):80-3. PubMed ID: 20185225
[TBL] [Abstract][Full Text] [Related]
23. The value of curettage in diagnosis of endometrial hyperplasia.
Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
[TBL] [Abstract][Full Text] [Related]
24. Endometrial sampling prior to hysterectomy.
Stovall TG; Solomon SK; Ling FW
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):405-9. PubMed ID: 2915864
[TBL] [Abstract][Full Text] [Related]
25. Agreement of histopathological findings of uterine curettage and hysterectomy specimens in women with abnormal uterine bleeding.
Moradan S; Ghorbani R; Lotfi A
Saudi Med J; 2017 May; 38(5):497-502. PubMed ID: 28439599
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of preoperative curettage in determining tumor type and grade in endometrial cancer.
Thanachaiviwat A; Thirapakawong C; Leelaphatanadit C; Chuangsuwanich T
J Med Assoc Thai; 2011 Jul; 94(7):766-71. PubMed ID: 21774280
[TBL] [Abstract][Full Text] [Related]
27. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.
Hunter JE; Tritz DE; Howell MG; DePriest PD; Gallion HH; Andrews SJ; Buckley SB; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1994 Oct; 55(1):66-71. PubMed ID: 7959270
[TBL] [Abstract][Full Text] [Related]
28. Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia.
Bilgin T; Ozuysal S; Ozan H; Atakan T
J Obstet Gynaecol Res; 2004 Jun; 30(3):205-9. PubMed ID: 15210044
[TBL] [Abstract][Full Text] [Related]
29. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
30. Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage.
Suh-Burgmann E; Hung YY; Armstrong MA
Obstet Gynecol; 2009 Sep; 114(3):523-529. PubMed ID: 19701030
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the histopathological diagnoses of preoperative dilatation and curettage and hysterectomy specimens.
Barut A; Barut F; Arikan I; Harma M; Harma MI; Ozmen Bayar U
J Obstet Gynaecol Res; 2012 Jan; 38(1):16-22. PubMed ID: 21917068
[TBL] [Abstract][Full Text] [Related]
32. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
Merisio C; Berretta R; De Ioris A; Pultrone DC; Rolla M; Giordano G; Tateo S; Melpignano M
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):107-11. PubMed ID: 16154046
[TBL] [Abstract][Full Text] [Related]
33. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
34. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.
Janicek MF; Rosenshein NB
Gynecol Oncol; 1994 Mar; 52(3):373-8. PubMed ID: 8157194
[TBL] [Abstract][Full Text] [Related]
35. Vascular "pseudo invasion" in laparoscopic hysterectomy specimens: a diagnostic pitfall.
Logani S; Herdman AV; Little JV; Moller KA
Am J Surg Pathol; 2008 Apr; 32(4):560-5. PubMed ID: 18300797
[TBL] [Abstract][Full Text] [Related]
36. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Gynecol Oncol; 2009 Apr; 113(1):105-8. PubMed ID: 19167049
[TBL] [Abstract][Full Text] [Related]
37. Endometrial hyperplasia - the dilemma of management remains: a retrospective observational study of 280 women.
Daud S; Jalil SS; Griffin M; Ewies AA
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):172-5. PubMed ID: 21764501
[TBL] [Abstract][Full Text] [Related]
38. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
[TBL] [Abstract][Full Text] [Related]
39. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
[TBL] [Abstract][Full Text] [Related]
40. Hysteroscopic biopsy compared with endometrial curettage to assess the preoperative rate of atypical hyperplasia underestimating endometrial carcinoma.
Garuti G; Sagrada PF; Frigoli A; Fornaciari O; Finco A; Mirra M; Soligo M
Arch Gynecol Obstet; 2023 Sep; 308(3):971-979. PubMed ID: 37160470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]